DESIGN, PREPARE AND IN VITRO EVALUATION OF NERATINIB LOADED ETHOSOMAL GEL
The present study aimed to formulate and evaluate a Neratinib-loaded ethosomal gel as a novel topical drug delivery system to enhance drug permeation, improve sustained release, and increase therapeutic efficacy. Eight Neratinib-loaded ethosomal formulations (F1–F8) were prepared using varying concentrations of phosphatidylcholine and subsequently incorporated into Carbopol 934 gel. The prepared formulations were evaluated for vesicle size, zeta potential, surface morphology, pH, viscosity, spreadability, entrapment efficiency, in vitro drug release, release kinetics, and stability. The ethosomal vesicles exhibited particle sizes ranging from 180 to 201 nm with zeta potential values between −22 and −28 mV, indicating nanosized, physically stable vesicles. SEM analysis confirmed spherical, smooth, and uniformly distributed ethosomes. Among all the formulations, F8 was identified as the optimized formulation, exhibiting the highest drug entrapment efficiency (96.32%), suitable viscosity (7258 cps), excellent spreadability (26.25 g·cm/sec), and maximum cumulative drug release of 99.12% over 12 hours. Drug release kinetic analysis revealed that the optimized formulation followed the Higuchi diffusion model (R² = 0.993), indicating diffusion-controlled sustained drug release. Accelerated stability studies conducted for three months demonstrated that the optimized formulation remained physically stable with no significant changes in drug content or formulation characteristics. The results of the present investigation indicate that Neratinib-loaded ethosomal gel is a promising topical drug delivery system capable of providing sustained drug release, enhanced stability, and improved drug permeation. This formulation has the potential to improve localized therapeutic efficacy while minimizing systemic side effects. Keywords: Neratinib, Phosphatidylcholine, Cold method, Ethosomes, Carbopol 934, In vitro drug release studies
Authors
- Reddy Nazemoon*, G . Pravalika
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24403828
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- preprint